ArticleCellular oncology (Dordrecht, Netherlands)2022

The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.

Wenying Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.